Search

file (10) (1)

OBI Information

News

HOMEWhat’s NewNews

2025.Feb.20

Corporate

OBI Pharma Showcases Proprietary ADC Platform GlycOBI® in China
Drawing Strong Industry Interest

2025.Feb.19

Corporate

Invited to the 2025 Healthcare Conference in Taipei
Dr. Heidi Wang engaged in discussions on Regulatory Landscape and International Partnerships in Pharma and Diagnostics

2024.Dec.31

Corporate

OBI Pharma's OBI-992 Research Paper Featured on Cover and Selected as a First Disclosure Article in Molecular Cancer Therapeutics Journal

2024.Dec.23

Corporate

OBI Pharma Enters Collaboration with GlyTech to Expand GlycOBI® Enabling Technologies Outreach in Japan and to Advance Glycan Production

2024.Dec.11

Sustainability

Award & Certification​

OBI Pharma Earns Sports Enterprise Certification Again
Building a Healthy Workplace and Fulfilling Sustainability Commitments

2024.Dec.02

Corporate

Key Technologies + Innovative Products + Flexible Business Models
Dr. Heidi Wang: Shaping OBI Pharma into a Leading and Thriving Global Biotech Company

2024.Nov.14

Corporate

OBI Pharma Showcases Biomarker Innovations at Singapore APAC Summit
Precision Medicine Tools Drive Success in New Drug Development

2024.Nov.07

Corporate

OBI-992 Ranks Among World ADC Award Top 8, Stands Strong Among Global Pharma Giants Despite Missing Top Prize, Gains Global Recognition

2024.Nov.07

Corporate

OBI Pharma Invited to Speak at World ADC Conference Innovative Linker Technology and GlycOBI® ADC Platform Capture Global Attention

2024.Oct.27

Corporate

OBI Pharma to Showcase Research Achievements and Cutting Edge ADC Platform Technology
Frequent Speaking Engagements at Prestigious International Conferences

Announcements

Latest announcements

Events

Latest events